RAM BIOTECH ApS: Financial statements 2022
CVR: 26923573
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
RAM BIOTECH ApS (CVR 26923573) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -26,069 and a net result of DKK -28,654 compared with DKK 71,835 the year before. Equity in the 2022 report amounted to DKK 308,254. The solvency ratio was 91.4%.
- Gross Profit
- DKK -26,069
- Profit/Loss
- DKK -28,654
- Equity
- DKK 308,254
- Total Assets
- DKK 337,151
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -26 t. | -29 t. | 308 t. | - |
| 2021 | - | 74 t. | 72 t. | 337 t. | - |
| 2020 | - | 47 t. | 47 t. | 265 t. | 0 |
| 2019 | - | 50 t. | 50 t. | 218 t. | 0 |
| 2018 | - | 57 t. | 57 t. | 169 t. | 0 |
Official annual report
Keep an eye on RAM BIOTECH ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
RAM BIOTECH ApS has published its annual report for 2021. Gross profit came to DKK 73,810, and the net result was DKK 71,835.
About RAM BIOTECH ApS
RAM BIOTECH ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2002. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The management consists of Morten Steen Hanefeld Dziegiel. The board consists of Leif Kofoed Nielsen (chair), Morten Steen Hanefeld Dziegiel and Rasmus Lundquist. The company is owned by Leif Kofoed Nielsen, Morten Steen Hanefeld Dziegiel and Lundquist Medical ApS. The company has 1 employee (2004). In 2025, the company reported a gross profit of DKK -22,479 and a net result of DKK -22,479 compared with DKK -29,439 the year before. Equity in the 2025 report amounted to DKK 231,758.